[Experimental substantiation of using immunomodulators of the phenylimidazothiazole type for the correction of secondary immunologic insufficiency caused by poliomyelitis virus].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000209:etiology; D051379:Mice; D008807:Mice, Inbred BALB C; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*
D000276:Adjuvants, Immunologic; D011055:Poliovirus Vaccine, Oral
Eksperimental'noe obosnovanie primeneniia immunomoduliatorov tipa fenilimidazotiazola dlia korrektsii vtorichnoĭ immunologicheskoĭ nedostatochnosti, obuslovlennoĭ virusami poliomielita.